3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
3
Colonic Neoplasms
3
Sarcopenia
2
Prostatic Neoplasms
2
Polycystic Ovary Syndrome
2
Diarrhea
2
Vaso-Occlusive Crises
1
Stomach Neoplasms
1
Seaweed Associated Changes in Healthy Subjects
1
Rectal Neoplasms
1
Proctitis
1
Neoplasms
1
Multiple Myeloma
1
Mucositis
1
Metabolic Syndrome
1
Malnutrition
1
Lymphoma
1
Liver Failure
1
Insulin Resistance
1
Hyperandrogenism
1
Head and Neck Neoplasms
1
Glucose Intolerance
1
Fibrosis
1
Colonic Polyps
1
Cholangiocarcinoma
1
Chemotherapy-related Diarrhea
1
Carcinoma, Hepatocellular
1
Anovulation
1
Anemia, Sickle Cell
1
Interventions
Metformin
7
Magnetic Resonance Spectroscopy
2
Inositol
2
Exercise
2
Ethinyl Estradiol
2
maltodextrin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Walking
1
Triptorelin Pamoate
1
Testosterone
1
Sugars
1
Spironolactone
1
Pyruvic Acid
1
Preoperative Exercise
1
Pioglitazone
1
Phlebotomy
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Leuprolide
1
Hepatectomy
1
Flutamide
1
Etanercept
1
Estrogens
1
Diet, Reducing
1
Diet, Mediterranean
1
Diet, Fat-Restricted
1
Diet Therapy
1
Diet
1
Diathermy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Metabolic Syndrome
×
maltodextrin
×
Clear all
NCT06852365
2026-02-19
COR-PCOS
University of Pennsylvania
Phase 2
Recruiting
100 enrolled